Peer-Reviewed Journal Details
Mandatory Fields
Landry WD, Woolley JF, Cotter TG
2013
February
Leukemia Research
Imatinib and Nilotinib inhibit Bcr-Abl-induced ROS through targeted degradation of the NADPH oxidase subunit p22phox.
Validated
WOS: 20 ()
Optional Fields
37
2
183
189
10.1016/j.leukres.2012.11.003
Grant Details